日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity

I型干扰素激活MHC I类分子修饰的CD11b+常规树突状细胞,从而促进保护性抗肿瘤CD8+ T细胞免疫。

Ellen Duong ,Tim B Fessenden ,Emi Lutz ,Teresa Dinter ,Leon Yim ,Sarah Blatt ,Arjun Bhutkar ,Karl Dane Wittrup ,Stefani Spranger

Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins

树突状细胞介导的肿瘤来源肽的交叉呈递倾向于针对质膜蛋白。

Tim B Fessenden ,Lauren E Stopfer ,Fiona Chatterjee ,Julian Zulueta ,Josh Mesfin ,Therese Cordero Dumit ,Irene Reijers ,Esmee P Hoefsmit ,Christian Blank ,Forest White ,Stefani Spranger

Dia1-dependent adhesions are required by epithelial tissues to initiate invasion

上皮组织需要 Dia1 依赖性粘附才能启动侵袭

Tim B Fessenden, Yvonne Beckham, Mathew Perez-Neut, Guillermina Ramirez-San Juan, Aparajita H Chourasia, Kay F Macleod, Patrick W Oakes, Margaret L Gardel

Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer

去势抵抗性前列腺癌对第二代雄激素受体拮抗剂恩杂鲁胺的获得性耐药

Steven Kregel, James L Chen, Westin Tom, Venkatesh Krishnan, Jacob Kach, Hannah Brechka, Tim B Fessenden, Masis Isikbay, Gladell P Paner, Russell Z Szmulewitz, Donald J Vander Griend

Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes

上皮应激的细胞外后果:促肿瘤组织表型的激活

Colleen A Fordyce, Kelley T Patten, Tim B Fessenden, RosaAnna DeFilippis, E Shelley Hwang, Jianxin Zhao, Thea D Tlsty